Form 4 for GH Guardant Health, Inc.
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-04 · accession 0001576280-25-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-05 | 2025-02-04 | GH | Joyce Meghan V. | Dir | M - OptEx | $0.00 | +66 | 7,747 | +0.9% | $0 |
| D | 2025-02-05 | 2025-02-04 | GH | Joyce Meghan V. | Dir | M - OptEx | $0.00 | -66 | 399 | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-04 | M | A | 66 | $0.00 | 7,747 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-02-04 | M | D | 66 | $0.00 | 399 | D | $0.00 · — to — | 66 Common Stock | (F1) The restricted stock unit vested as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares vest in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. (F2) Not applicable for Restricted Stock Units. |